In the BioHarmony Drug Report Database
Cocaine
Goprelto, Numbrino (cocaine) is a small molecule pharmaceutical. Cocaine was first approved as Goprelto on 2017-12-14. It is used to treat cough and pain in the USA. The pharmaceutical is active against sodium-dependent dopamine transporter. In addition, it is known to target 5-hydroxytryptamine receptor 3A and soluble acetylcholine receptor. Goprelto’s patent is valid until 2037-02-07 (FDA).
Trade Name
|
Goprelto, Numbrino |
|---|---|
Common Name
|
cocaine |
ChEMBL ID
|
CHEMBL370805 |
Indication
|
cough, pain |
Drug Class
|
Local anesthetics |
Image (chem structure or protein)